Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Second primary malignancies in thyroid cancer patients.

Rubino C, de Vathaire F, Dottorini ME, Hall P, Schvartz C, Couette JE, Dondon MG, Abbas MT, Langlois C, Schlumberger M.

Br J Cancer. 2003 Nov 3;89(9):1638-44.

2.

Leukaemias and cancers following iodine-131 administration for thyroid cancer.

de Vathaire F, Schlumberger M, Delisle MJ, Francese C, Challeton C, de la Genardiére E, Meunier F, Parmentier C, Hill C, Sancho-Garnier H.

Br J Cancer. 1997;75(5):734-9.

3.

A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations.

Brown AP, Neeley ES, Werner T, Soisson AP, Burt RW, Gaffney DK.

Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):127-35. doi: 10.1016/j.ijrobp.2009.07.1692. Epub 2009 Nov 10.

PMID:
19910129
4.

Thyroid adenomas and carcinomas following radiotherapy for a hemangioma during infancy.

Haddy N, Andriamboavonjy T, Paoletti C, Dondon MG, Mousannif A, Shamsaldin A, Doyon F, Labbé M, Robert C, Avril MF, Fragu P, Eschwege F, Chavaudra J, Schvartz C, Lefkopoulos D, Schlumberger M, Diallo I, de Vathaire F.

Radiother Oncol. 2009 Nov;93(2):377-82. doi: 10.1016/j.radonc.2009.05.011. Epub 2009 Jun 8.

PMID:
19515442
5.

Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.

Liauw SL, Sylvester JE, Morris CG, Blasko JC, Grimm PD.

Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):669-73. Epub 2006 Aug 2.

PMID:
16887293
6.

Subsequent malignancies in patients treated with 131-iodine for thyroid cancer.

Glanzmann C.

Strahlenther Onkol. 1992 Jun;168(6):337-43.

PMID:
1621212
7.

Incidence of second primary malignancies during a long-term surveillance of patients with differentiated thyroid carcinoma in relation to radioiodine treatment.

Fallahi B, Adabi K, Majidi M, Fard-Esfahani A, Heshmat R, Larijani B, Haghpanah V.

Clin Nucl Med. 2011 Apr;36(4):277-82. doi: 10.1097/RLU.0b013e31820a9fe3.

PMID:
21368600
8.

High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group.

Bhatia S, Yasui Y, Robison LL, Birch JM, Bogue MK, Diller L, DeLaat C, Fossati-Bellani F, Morgan E, Oberlin O, Reaman G, Ruymann FB, Tersak J, Meadows AT; Late Effects Study Group.

J Clin Oncol. 2003 Dec 1;21(23):4386-94.

PMID:
14645429
9.

Thyroid carcinoma presenting in childhood or after treatment of childhood malignancies: An institutional experience and review of the literature.

Gow KW, Lensing S, Hill DA, Krasin MJ, McCarville MB, Rai SN, Zacher M, Spunt SL, Strickland DK, Hudson MM.

J Pediatr Surg. 2003 Nov;38(11):1574-80. Review.

PMID:
14614703
10.

Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment.

Rubino C, Shamsaldin A, Lê MG, Labbé M, Guinebretière JM, Chavaudra J, de Vathaire F.

Breast Cancer Res Treat. 2005 Feb;89(3):277-88.

PMID:
15754127
11.

Risk of second primary malignancy in differentiated thyroid carcinoma treated with radioactive iodine therapy.

Lang BH, Wong IO, Wong KP, Cowling BJ, Wan KY.

Surgery. 2012 Jun;151(6):844-50. doi: 10.1016/j.surg.2011.12.019. Epub 2012 Feb 15.

PMID:
22341041
12.

Thyroid cancer after diagnostic administration of iodine-131.

Hall P, Mattsson A, Boice JD Jr.

Radiat Res. 1996 Jan;145(1):86-92.

PMID:
8532842
13.
14.

The risk of multiple primary breast and thyroid carcinomas.

Adjadj E, Rubino C, Shamsaldim A, Lê MG, Schlumberger M, de Vathaire F.

Cancer. 2003 Sep 15;98(6):1309-17.

15.

Thyroid adenomas after solid cancer in childhood.

Haddy N, El-Fayech C, Guibout C, Adjadj E, Thomas-Teinturier C, Oberlin O, Veres C, Pacquement H, Jackson A, Munzer M, N'Guyen TD, Bondiau PY, Berchery D, Laprie A, Bridier A, Lefkopoulos D, Schlumberger M, Rubino C, Diallo I, de Vathaire F.

Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):e209-15. doi: 10.1016/j.ijrobp.2012.03.044. Epub 2012 Jun 5.

PMID:
22672756
16.
17.

Childhood thyroid cancers and radioactive iodine therapy: necessity of precautious radiation health risk management.

Kumagai A, Reiners C, Drozd V, Yamashita S.

Endocr J. 2007 Dec;54(6):839-47. Epub 2007 Oct 15. Review.

18.

Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.

MacArthur AC, Spinelli JJ, Rogers PC, Goddard KJ, Phillips N, McBride ML.

Pediatr Blood Cancer. 2007 Apr;48(4):453-9.

PMID:
16767718
19.

Risk of thyroid cancer after exposure to 131I in childhood.

Cardis E, Kesminiene A, Ivanov V, Malakhova I, Shibata Y, Khrouch V, Drozdovitch V, Maceika E, Zvonova I, Vlassov O, Bouville A, Goulko G, Hoshi M, Abrosimov A, Anoshko J, Astakhova L, Chekin S, Demidchik E, Galanti R, Ito M, Korobova E, Lushnikov E, Maksioutov M, Masyakin V, Nerovnia A, Parshin V, Parshkov E, Piliptsevich N, Pinchera A, Polyakov S, Shabeka N, Suonio E, Tenet V, Tsyb A, Yamashita S, Williams D.

J Natl Cancer Inst. 2005 May 18;97(10):724-32.

PMID:
15900042
20.

Radiation exposure and familial aggregation of cancers as risk factors for colorectal cancer after radioiodine treatment for thyroid carcinoma.

Rubino C, Adjadj E, Doyon F, Shamsaldin A, Abbas TM, Caillou B, Colonna M, Cecarreli C, Schvartz C, Bardet S, Langlois C, Ricard M, Schlumberger M, de Vathaire F.

Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1084-9.

PMID:
15990012

Supplemental Content

Support Center